This FDA InspectorProfile is a report of relevant audit-related information on Xiaokuang Lai, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.
This InspectorProfile report is updated through and lists Xiaokuang Lai's inspections in 17 countries: Japan, United States, Serbia, Italy, Finland, Germany, India, Singapore, Ireland, Belgium, Taiwan, Switzerland, Romania, Austria, China, France, and United Kingdom.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Xiaokuang Lai's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Xiaokuang Lai.
Note: The EIR and 483 documents are sold separately.